AAHP Reader Favorites of 2025
As 2025 winds down, we’re taking a moment to revisit the articles that resonated most with our community this year. These five top reads captured attention, highlighted key conversations, and reflected the topics shaping our industry. Your engagement continues to drive AAHP’s work, and we look forward to bringing you new resources, practical guidance, and timely updates as we head into 2026.
1. The FDA Adverse Event Reporting System (FAERS)
Our most-read article of 2025 provided an important walkthrough of the FDA’s FAERS dashboard by Kristina Skowronek, Director of Quality and Regulatory Compliance at Boiron, Inc. As the article explains, regularly checking FAERS helps manufacturers analyze key trends related to patient experiences and adverse events that they might not otherwise notice. It highlights what to look for in the database and how to use the information effectively, including when clearer communication on product labels could help reduce off-label use.
2. Lowest Permissible Attenuation
Our second most viewed article of 2025 was written by AAHP Secretary and HPCUS Senior Scientist Eric L. Foxman and focuses on the HPCUS’s update to an important industry term. The familiar phrase “First Safe Dilution” has received a makeover for accuracy, and the organization has now adopted the term “Lowest Permissible Attenuation.” In this article, Eric explains why the change matters, what it reflects about current scientific and regulatory understanding, and how it may impact your company’s practices.
Our third most viewed article of 2025 highlights one of AAHP’s most popular resources: our webpage of frequently asked questions. This fact sheet, compiled from the materials AAHP uses when introducing homeopathy to Congressional health staff on Capitol Hill, offers clear and accessible answers to common questions about the field. Take a moment to revisit this helpful overview and explore the complete list of Q&A.
4. Ensuring “Safety” Remains the Hallmark of Homeopathic OTCs
Our fourth most viewed article of 2025 comes from AAHP President Mark Land, M.S., RAC-US. In this President’s Message from our February edition, Mark reflects on the longstanding reputation of homeopathic OTC products for safety and the continued vigilance required to maintain that trust. The article reviews key safety measures in homeopathic drug development, including calculating safe ingredient levels, monitoring adverse events through FDA systems, and learning from industry experiences with nitrosamine risks. Revisit this informative piece to refresh your understanding of the practices that help protect both products and consumers.
5. Highlights of the 2025 Homeopathic Research Institute Conference in Greece
Our fifth most viewed article of 2025 takes readers to HRI’s 6th international conference, held this June in Thessaloniki, Greece. This piece skims the surface of presentations from 66 researchers who shared groundbreaking work across clinical, fundamental, veterinary, and agricultural homeopathy. Take a look back to see which studies made AAHP’s list to highlight with a short synopsis.